Total Payments
$8,000
2024 Payments
$1,569
Companies
45
Transactions
347
Medicare Patients
8,667
Medicare Billing
$667,638

Payment Breakdown by Category

Food & Beverage$8,000 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $8,000 347 100.0%

Top Paying Companies

Company Total Records Latest Year
Davol Inc. $980.41 14 $0 (2024)
Boston Scientific Corporation $831.15 22 $0 (2024)
Astellas Pharma US Inc $812.78 46 $0 (2024)
Integra LifeSciences Corporation $527.76 7 $0 (2024)
Dendreon Pharmaceuticals LLC $514.75 26 $0 (2024)
COLOPLAST CORP $445.17 23 $0 (2024)
PFIZER INC. $413.99 28 $0 (2024)
Antares Pharma, Inc. $270.72 16 $0 (2024)
Sumitomo Pharma America, Inc. $268.27 17 $0 (2024)
Endo Pharmaceuticals Inc. $253.61 17 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,569 67 Davol Inc. ($160.19)
2023 $2,042 85 Integra LifeSciences Corporation ($341.48)
2022 $1,576 63 Davol Inc. ($381.67)
2021 $791.83 32 Boston Scientific Corporation ($352.53)
2020 $594.87 19 Boston Scientific Corporation ($227.64)
2019 $416.73 30 Astellas Pharma US Inc ($129.61)
2018 $330.50 23 Astellas Pharma US Inc ($114.29)
2017 $679.75 28 Astellas Pharma US Inc ($282.21)

All Payment Transactions

347 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
12/10/2024 Olympus America Inc. Bovie (Device) Food and Beverage In-kind items and services $15.85 General
Category: Urology Gynecology
12/03/2024 Myriad Genetic Laboratories, Inc. PROLARIS (Device) Food and Beverage In-kind items and services $24.45 General
Category: ONCOLOGY
11/19/2024 Ferring Pharmaceuticals Inc. ADSTILADRIN (Biological) Food and Beverage In-kind items and services $26.19 General
Category: ONCOLOGY
11/15/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $16.23 General
Category: TESTOSTERONE REPLACEMENT THERAPY
11/11/2024 Laborie Medical Technologies Corp. Urgent PC Neuromodulation System (Device) Food and Beverage Cash or cash equivalent $15.34 General
Category: Urology
11/05/2024 PROCEPT BioRobotics Corporation AQUABEAM SYSTEM (Device) Food and Beverage Cash or cash equivalent $117.12 General
Category: UROLOGY
11/05/2024 Baxter Healthcare PERCLOT (Device) Food and Beverage In-kind items and services $57.56 General
Category: Surgical Care
11/05/2024 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $16.71 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
11/04/2024 PFIZER INC. XTANDI (Drug), ORGOVYX Food and Beverage In-kind items and services $20.48 General
Category: ONCOLOGY
10/29/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $18.84 General
Category: HORMONE THERAPY
10/28/2024 Myriad Genetic Laboratories, Inc. PROLARIS (Device) Food and Beverage In-kind items and services $16.38 General
Category: ONCOLOGY
10/24/2024 Davol Inc. ARISTA AH FlexiTip (Device) Food and Beverage In-kind items and services $89.71 General
Category: Surgery
10/24/2024 Davol Inc. Phasix Mesh (Device) Food and Beverage In-kind items and services $70.48 General
Category: Surgery
10/23/2024 Boston Scientific Corporation LithoVue (Device) Food and Beverage In-kind items and services $63.79 General
Category: LithoVue_URO
10/22/2024 180 Medical, Inc. Food and Beverage In-kind items and services $29.36 General
10/21/2024 Ferring Pharmaceuticals Inc. ADSTILADRIN (Biological) Food and Beverage In-kind items and services $21.12 General
Category: ONCOLOGY
10/15/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $16.58 General
Category: BOTOX THERAPEUTIC
10/10/2024 COLOPLAST CORP SpeediCath (Device) Food and Beverage In-kind items and services $19.70 General
Category: Continence Care
10/08/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $19.73 General
Category: ONCOLOGY
09/30/2024 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $13.24 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
09/23/2024 ACCORD HEALTHCARE, INC. CAMCEVI (Drug) Food and Beverage In-kind items and services $21.20 General
Category: Oncology
09/17/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $18.02 General
Category: TESTOSTERONE REPLACEMENT THERAPY
09/16/2024 Telix Pharmaceuticals ILLUCCIX (Drug), ILLUCCIX Food and Beverage In-kind items and services $15.97 General
Category: PROSTATE CANCER DIAGNOSIS
09/11/2024 Ferring Pharmaceuticals Inc. ADSTILADRIN (Biological) Food and Beverage In-kind items and services $23.22 General
Category: ONCOLOGY
08/16/2024 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $17.30 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 26 2,647 3,463 $1.6M $202,190
2022 21 2,198 2,877 $1.2M $170,992
2021 21 1,971 2,545 $719,513 $157,211
2020 20 1,851 2,368 $518,016 $137,244
Total Patients
8,667
Total Services
11,253
Medicare Billing
$667,638
Procedure Codes
94

All Medicare Procedures & Services

94 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 458 607 $304,107 $42,583 14.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 290 337 $239,270 $30,163 12.6%
52000 Diagnostic exam of bladder and urethra using an endoscope Office 2023 108 134 $179,962 $26,860 14.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 141 154 $163,856 $21,424 13.1%
55867 Simple surgical subtotal removal of prostate using laparoscope Facility 2023 14 14 $108,738 $12,201 11.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 74 86 $84,968 $11,532 13.6%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 107 149 $56,918 $9,327 16.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 97 97 $59,752 $8,110 13.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 62 62 $56,730 $7,890 13.9%
51702 Simple insertion of temporary bladder tube Office 2023 24 80 $28,960 $3,916 13.5%
55700 Biopsy of prostate gland Office 2023 18 18 $25,362 $3,758 14.8%
52332 Insertion of stent in ureter using an endoscope Facility 2023 21 27 $68,715 $3,161 4.6%
51798 Ultrasound measurement of bladder capacity after voiding Office 2023 237 314 $18,840 $2,842 15.1%
51797 Insertion of device into abdomen with pressure and urine flow rate study Office 2023 14 14 $15,162 $2,388 15.7%
55700 Biopsy of prostate gland Facility 2023 21 21 $29,589 $2,252 7.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 13 13 $15,691 $2,239 14.3%
81003 Automated urinalysis test Office 2023 656 989 $16,319 $2,164 13.3%
76770 Complete ultrasound scan behind abdominal cavity Office 2023 29 32 $19,968 $2,026 10.1%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 32 39 $12,129 $1,888 15.6%
76872 Ultrasound scan of pelvic region through rectum Office 2023 18 18 $14,382 $1,516 10.5%
76942 Ultrasonic guidance for needle placement Office 2023 18 18 $5,814 $729.98 12.6%
96372 Injection of drug or substance under skin or into muscle Office 2023 46 60 $4,740 $715.67 15.1%
76872 Ultrasound scan of pelvic region through rectum Facility 2023 21 21 $16,779 $561.75 3.3%
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle Office 2023 13 22 $4,092 $555.52 13.6%
76942 Ultrasonic guidance for needle placement Facility 2023 20 20 $6,460 $504.80 7.8%

About Robert Bonitz

Robert Bonitz is a Student in an Organized Health Care Education/Training Program healthcare provider based in Shrewsbury, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2012. The National Provider Identifier (NPI) number assigned to this provider is 1104182716.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Bonitz has received a total of $8,000 in payments from pharmaceutical and medical device companies, with $1,569 received in 2024. These payments were reported across 347 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($8,000).

As a Medicare-enrolled provider, Bonitz has provided services to 8,667 Medicare beneficiaries, totaling 11,253 services with total Medicare billing of $667,638. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.

Practice Information

Products in Payments

  • XTANDI (Drug) $556.52
  • Integra (Device) $527.76
  • PROVENGE (Drug) $514.75
  • ORGOVYX (Drug) $299.50
  • INTERSTIM (Device) $276.12
  • SpeediCath (Device) $270.63
  • XIAFLEX (Biological) $270.14
  • Phasix Mesh (Device) $233.39
  • LITHOVUE (Device) $220.35
  • Xtandi (Drug) $211.60
  • XYOSTED (Drug) $199.12
  • AMS (Device) $198.22
  • BOTOX (Biological) $189.00
  • Myrbetriq (Drug) $165.02
  • ARISTA AH FlexiTip (Device) $163.92
  • ARISTA AH FLEXITIP (Device) $160.56
  • LithoVue (Device) $155.37
  • GEMTESA (Drug) $151.45
  • AQUABEAM SYSTEM (Device) $150.45
  • XENAB (Device) $147.12

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Shrewsbury